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Parasitic infections can modify the host´s ability to metabolize drugs and other 
xenobiotics by altering the biotransformation enzymes. These changes may have various 
pharmacological, toxicological or physiological consequences. In our study, in vitro 
metabolism of albendazole, albendazole sulfoxide and flubendazole was tested and compared 
in non-infected mouflons and in mouflons infected by lancet fluke (Dicrocoelium 
dendriticum). Two groups of 5-7 years old mouflon ewes (Ovis musimon) were used for our 
study. Animals in the first group were parasitologically negative and the second group 
consisted of fluke positive animals. Subcellular fractions of liver homogenates from 
non-infected and Dicrocoelium-infected mouflons were isolated. The hepatic microsomal and 
cytosolic fractions were incubated with albendazole, albendazole sulfoxide or flubendazole. 
The anthelmintics and their metabolites were analyzed using HPLC. Apparent kinetic 
parameters (Vmax and Km) of biotransformation reactions were investigated and compared 
in non-infected mouflons and in Dicrocoelium-infected mouflons. 
Protein concentrations in cytosolic fractions were higher in non-infected mouflons 
than in Dicrocoelium-infected mouflons. In microsomal fractions of both non-infected and 
infected mouflons, albendazole was metabolized through two-step S-oxidation yielding first 
albendazole sulfoxide followed by albendazole sulfone. Albendazole sulfoxide was converted 
to albendazole sulfone in microsomes. In cytosolic fractions albendazole was not oxidized. 
Either in microsomal or in cytosolic fractions, albendazole sulfoxide was not reduced 
to albendazole. In microsomal and cytosolic fractions of both non-infected and infected 
mouflons, flubendazole was metabolized only through reduction of carbonyl group, 
hydrolyzed metabolite of flubendazole was not formed. Dicrocoeliosis enhanced the 
formation of either albendazole sulfoxide or albendazole sulfone. Affinity 
of biotransformation enzymes for albendazole was significantly higher in 
Dicrocoelium-infected mouflons than in non-infected mouflons. Apparent Km for 
flubendazole reduction in microsomes was also influenced by dicrocoeliosis. Affinity of 
reductases for flubendazole was higher in non-infected mouflons than mouflons with 
dicrocoeliosis.  
Stereospecificity of albendazole oxidation was also affected by dicrocoeliosis. 
Dicrocoeliosis in mouflon increased (+)-ABZSO formation. Reduction of flubendazole is 
highly stereospecific in mouflon and it is not affected by dicrocoeliosis, only (+)-FLU-R was 
formed in both non-infected and infected mouflons. 
In conclusion, dicrocoeliosis in mouflons caused only mild changes in albendazole, 
albendazole sulfoxide and flubendazole hepatic biotransformation. Undesirable alterations 
in pharmacokinetics of mentioned benzimidazole anthelmintics are not expected.  
 
